HIV

Showing 5 posts of 200 posts found.

FDA approves Pfizer’s first-in-class HIV drug

August 8, 2007
Sales and Marketing HIV

Pfizer has won US approval for Selzentry, making it the first new class of oral HIV medicines to reach the …

Gates Foundation could rival pharma, analysts warn

May 15, 2007
Sales and Marketing Gates Foundation, HIV, TB, vaccines

 The pharmaceutical industry could suffer a blow to its reputation, and could even suffer commercially, if it fails to appreciate …

Abbott lowers prices on HIV drugs

April 12, 2007
Sales and Marketing HIV, par

Intervention from the World Health Organisation has spurred Abbott to lower its prices on HIV drugs in developing countries.The company …

HIV market: collaborative combinations

March 26, 2007
Research and Development, Sales and Marketing HIV, drug development, marketing

Two new HIV drugs, from Tibotec and Gilead, have been shown to be viable late-stage pipeline candidates. However, both TMC278 …

Abbott withdraws HIV drugs from Thailand after patent row

March 21, 2007
Sales and Marketing HIV

Abbott Laboratories' tit-for-tat decision to withold new HIV treatments from Thailand has drawn an angry response from the Aids Healthcare …

The Gateway to Local Adoption Series

Latest content